Matzim LA - 52544-693-30 - (Diltiazem Hydrochloride)

Alphabetical Index


Drug Information of Matzim LA

Product NDC: 52544-693
Proprietary Name: Matzim LA
Non Proprietary Name: Diltiazem Hydrochloride
Active Ingredient(s): 300    mg/1 & nbsp;   Diltiazem Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Matzim LA

Product NDC: 52544-693
Labeler Name: Watson Pharma, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077686
Marketing Category: ANDA
Start Marketing Date: 20110328

Package Information of Matzim LA

Package NDC: 52544-693-30
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-693-30)

NDC Information of Matzim LA

NDC Code 52544-693-30
Proprietary Name Matzim LA
Package Description 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-693-30)
Product NDC 52544-693
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Diltiazem Hydrochloride
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20110328
Marketing Category Name ANDA
Labeler Name Watson Pharma, Inc.
Substance Name DILTIAZEM HYDROCHLORIDE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]

Complete Information of Matzim LA


General Information